| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.41 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |